About Slava Therapeutics
Slava Therapeutics was a Healthcare company based in Hyderabad (India) founded in 2017 by Mohanakrishna Gopinath and Sirisha Pilla. Manufacturer of generic drugs. It operates on a Traditional Pharmaceuticals model. Its chief executive, as recorded, is Mohanakrishna Gopinath. Its Indian entity Slava Therapeutics Private Limited reported revenue of ₹12.14 Cr. The company is recorded as dissolved. Slava Therapeutics offers products and services including Slava Therapeutics Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Slava Therapeutics, founded in 2017 in Hyderabad, India, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Hyderabad, India
- Founders Mohanakrishna Gopinath, Sirisha Pilla
- SectorsHealthcare
- Website slavatherapeutics.com
- Legal Name Slava Therapeutics Private Limited
- Date of Incorporation 06 Jul, 2017
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹12.14 Cr
FY 2020 · +138% YoY
- Net Profit₹18.4 Lakh
FY 2020 · 2% margin
- EBITDA₹29.7 Lakh
FY 2020 · 2% margin
Associated legal entities of Slava Therapeutics
Slava Therapeutics operates through Slava Therapeutics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2020) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Slava Therapeutics Private Limited CIN U24304TG2017PTC118116 | Active | 06 Jul 2017 | Hyderabad, Telangana | ₹12.1 Cr | 2 | View details |
Products & Services of Slava Therapeutics
Slava Therapeutics offers a comprehensive portfolio of products and services, including Slava Therapeutics Platform.
Manufacturer of generic drugs
Board of directors of Slava Therapeutics Private Limited (Slava Therapeutics)
Slava Therapeutics Private Limited is the primary company behind Slava Therapeutics. The board of Slava Therapeutics Private Limited currently have 2 directors; the longest-serving is Sirisha Pilla, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sirisha Pilla DIN 07816397 | Director | 06 Jul 2017 | 9 yrs 4 mo | Slava Therapeutics Private Limited |
| Mohana Krishna Gopinath DIN 02964817 | Director | 13 Nov 2020 | 5 yrs 11 mo | Slava Therapeutics Private Limited |
People of Slava Therapeutics
2 people are tracked at Slava Therapeutics (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Slava Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Slava Therapeutics
Figures of Slava Therapeutics Private Limited, the primary company behind Slava Therapeutics, for FY 2020. Revenue was ₹12.14 Cr (+138% year on year). Net profit was ₹18.4 Lakh (2% margin). EBITDA was ₹29.7 Lakh (2% margin).
- ₹12.14 CrRevenue · FY 2020 · +138% YoY
- ₹18.4 LakhNet profit · 2% margin
- ₹29.7 LakhEBITDA · 2% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Slava Therapeutics Private Limited are on its company page.
Detailed financial statements for Slava Therapeutics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Slava Therapeutics
Slava Therapeutics was founded in 2017.
Slava Therapeutics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Mohanakrishna Gopinath is the CEO of Slava Therapeutics, as recorded in our data. They have also founded this company.
The primary company behind Slava Therapeutics, Slava Therapeutics Private Limited, reported revenue of ₹12.14 Cr for FY 2020, up 138% year on year.
Slava Therapeutics, founded in 2017 in Hyderabad, India, focuses on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic drugs. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Slava Therapeutics offers Slava Therapeutics Platform.
Slava Therapeutics operates through Slava Therapeutics Private Limited.
The legal entities of Slava Therapeutics currently have 2 directors, including Sirisha Pilla, Mohana Krishna Gopinath.